Glycogen storage disease type 2 Clinical Trials
Conditions / Glycogen storage disease type 2
Delta Trials indexes 3 clinical trials for Glycogen storage disease type 2 in its publicly accessible dataset. Of these, 0 enrolling participants at this time and 1 trial have reached completion. This research takes place spanning 33 research sites around the world. An additional 2 trials are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
3
Total Trials
0
Recruiting
1
Completed
2
Other Active
0
Terminated since 2020
33
Study Locations
Browse by location (33 total)
- Messina, Italy 2 trialsAll trials in Messina, Italy
- Phoenix, United States 2 trialsAll trials in Phoenix, United States
- Kansas City, United States 2 trialsAll trials in Kansas City, United States
- Salford, United Kingdom 2 trialsAll trials in Salford, United Kingdom
- Marseille, France 2 trialsAll trials in Marseille, France
- Portland, United States 2 trialsAll trials in Portland, United States
- Orange, United States 2 trialsAll trials in Orange, United States
- Garches, France 2 trialsAll trials in Garches, France
- Pisa, Italy 2 trialsAll trials in Pisa, Italy
- Minneapolis, United States 2 trialsAll trials in Minneapolis, United States
- Munchen, Germany 2 trialsAll trials in Munchen, Germany
- Mȕnchen, Germany 2 trialsAll trials in Mȕnchen, Germany
- Műnchen, Germany 2 trialsAll trials in Műnchen, Germany
- München, Germany 2 trialsAll trials in München, Germany
- Torino, Italy 2 trialsAll trials in Torino, Italy
- Nice, France 2 trialsAll trials in Nice, France
- Rotterdam, Netherlands 2 trialsAll trials in Rotterdam, Netherlands
- Milan, Italy 2 trialsAll trials in Milan, Italy
- Pittsburgh, United States 2 trialsAll trials in Pittsburgh, United States
- Aarhus C, Denmark 1 trialAll trials in Aarhus C, Denmark